Sfoglia per AUTORE
RENDINA M
Collezione ASL Città di Torino

  

Items : 8

VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease

2020
ASL Città di Torino

Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...

Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease

2019
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...

Decline of prevalence of resistance associated substitutions to NS3 and NS5A inhibitors at DAA failure in hepatitis C virus in Italy over the years 2015 to 2018 in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Zazzi M; Craxì A; Federico Perno C; Angelico M; Andreoni M; Rizzardini G; Raimondo G; Battista Gaeta G; Lampertico P; Babudieri S; Caudai C; Cuomo N; Santantonio TA; Pollicino T; Brunetto MR; Andreone P; Borghi V; Aghemo A; Ciancio A; Cariti G; Giorgini A; Palitti VP; Ciaccio A; Licata A; Lenci I; Biolato M; Sangiovanni V; Prestileo T; et alii...

Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. in Lancet (London, England) / Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1.

2018
AOU Città della Salute di Torino
ASL Città di Torino

Caraceni P; Riggio O; Angeli P; Alessandria C; Neri S; Foschi FG; Levantesi F; Airoldi A; Boccia S; Svegliati-Baroni G; Fagiuoli S; Romanelli RG; Cozzolongo R; Di Marco V; Sangiovanni V; Morisco F; Toniutto P; Tortora A; De Marco R; Angelico M; Cacciola I; Elia G; Federico A; Massironi S; Guarisco R; Galioto A; Ballardini G; Rendina M; Nardelli S; et alii...

Comparison of resistance profiles among DAA-naive and DAAexperienced patients infected with HCV non-1 genotype in Italy in Journal of Hepatology

2018
ASL Città di Torino

Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy in Digestive and Liver Disease

2018
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...

Characteristic and prevalence of NS3, NS5A and NS5B resistance associated substitutions in DAA-naive and DAA-failed HCV-3 patients in italy in Hepatology

2017
ASL Città di Torino

Craxi A; Taliani G; Raimondo G; Ciaccio A; Sangiovanni V; Cariti G; Bonora S; Aghemo A; Vullo V; Foroghi L; Calvaruso V; Morisco F; Lleo A; Ciancio A; Maserati R; Brancaccio G; Puoti M; Toniutto P; Pollicino T; Paolucci S; Coppola N; Ruggiero T; Bruzzone B; Palitti VP; Gianserra L; Polilli E; Teti E; Lenci I; Aragri M; et alii...